The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
The IL-2 Receptor β Chain (p70): Role in Mediating Signals for LAK, NK, and Proliferative Activities
Abstract
Interleukin-2 (IL-2) induces cytolytic activity and proliferation of human blood lymphocytes. Yet, prior to activation, these cells do not express IL-2 receptors recognized by monoclonal antibodies to the Tac antigen. A novel glycoprotein (IL-2Rβ), identified on several lymphocytoid cell lines, has the ability to bind IL-2 alone and to associate with Tac antigen (IL-2Rα) to form high-affinity IL-2 receptors. It is now reported that IL-2Rβ is expressed on both circulating T lymphocytes and large granular lymphocytes in quantities approximately proportional to their responsiveness to IL-2. Studies of the responses of these cells to IL-2 suggest that IL-2Rβ mediates the initial phase of induction of lymphokine activated killer (LAK), natural killer (NK), and proliferative activities. Subsequently, IL-2Rα is induced and functional high-affinity IL-2 receptors are expressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Uchiyama, T., Broder, S., & Waldmann, T. A. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.4.1393 · Cited by 1,329
Lanier, L. L., Le, A. M., Civin, C. I., Loken, M. R., & Phillips, J. H. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.12.4480 · Cited by 1,129
Characteristics of human large granular lymphocytes and relationship to natural killer and K cells
Timonen, T., JR, O., & Herberman, R. (1981) · The Journal of Experimental Medicine · doi:10.1084/jem.153.3.569 · Cited by 987
Leonard, W. J., Depper, J. M., Uchiyama, T., Smith, K. A., Waldmann, T. A., & Greene, W. C. (1982) · Nature · doi:10.1038/300267a0 · Cited by 864
Self-citationRobb, R. J., Greene, W. C., & Rusk, C. M. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.4.1126 · Cited by 725
Phillips, J. H., & Lanier, L. L. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.3.814 · Cited by 684
Response of resting human peripheral blood natural killer cells to interleukin 2.
Trinchieri, G., Matsumoto-Kobayashi, M., Clark, S. C., Seehra, J., London, L., & Perussia, B. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.4.1147 · Cited by 604
Novel Interleukin-2 Receptor Subunit Detected by Cross-Linking Under High-Affinity Conditions
Sharon, M., Klausner, R. D., Cullen, B. R., Chizzonite, R., & Leonard, W. J. (1986) · Science · doi:10.1126/science.3095922 · Cited by 572
Self-citationInterleukin 2 high-affinity receptor expression requires two distinct binding proteins.
Teshigawara, K., Wang, H. M., Kato, K., & Smith, K. A. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.1.223 · Cited by 548
Isolation of human NK cells by density gradient centrifugation
Timonen, T. T., & SAKSELA, E. (1980) · Journal of Immunological Methods · doi:10.1016/0022-1759(80)90133-7 · Cited by 482
Cited by
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Interleukin-2: Inception, Impact, and Implications
Smith, K. A. (1988) · Science · doi:10.1126/science.3131876 · Cited by 2,153
Noguchi, M. (1993) · Cell · doi:10.1016/0092-8674(93)90167-o · Cited by 1,320
Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A., & Alt, F. W. (1995) · Immunity · doi:10.1016/1074-7613(95)90180-9 · Cited by 1,080
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Liao, W., Lin, J.-X., & Leonard, W. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.01.004 · Cited by 1,075
Self-citationDefective lymphoid development in mice lacking expression of the common cytokine receptor γ chain
Cao, X., Shores, E. W., Hu-Li, J., Anver, M. R., Kelsail, B. L., Russell, S. M., Drago, J., Noguchi, M., Grinberg, A., Bloom, E. T., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90047-0 · Cited by 1,038
Self-citationBiology and clinical relevance of human natural killer cells
Robertson, M., & Ritz, J. (1990) · Blood · doi:10.1182/blood.v76.12.2421.2421 · Cited by 931
Lin, J.-X., Migone, T.-S., Tseng, M., Friedmann, M., Weatherbee, J. A., Zhou, L., Yamauchi, A., Bloom, E. T., Mietz, J., John, S., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90141-8 · Cited by 752
Self-citationLiao, W., Lin, J.-X., & Leonard, W. J. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.08.003 · Cited by 745
Self-citationTreg cell-based therapies: challenges and perspectives
Raffin, C., Vo, L. T., & Bluestone, J. A. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0232-6 · Cited by 720
Biology and regulation of IL-2: from molecular mechanisms to human therapy
Spolski, R., Li, P., & Leonard, W. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0046-y · Cited by 637
Self-citationMosley, B., Beckmann, M. P., March, C. J., Idzerda, R. L., Gimpel, S. D., VandenBos, T., Friend, D., Alpert, A., Anderson, D., Jackson, J., et al. (1989) · Cell · doi:10.1016/0092-8674(89)90295-x · Cited by 624
Hatakeyama, M., Kono, T., Kobayashi, N., Kawahara, A., Levin, S. D., Perlmutter, R. M., & Taniguchi, T. (1991) · Science · doi:10.1126/science.2047859 · Cited by 561
Biology of the Interleukin-2 Receptor
Nelson, B. H., & Willerford, D. M. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60386-7 · Cited by 475
Siegel, J. P., & Puri, R. K. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.4.694 · Cited by 465
Self-citationCaligiuri, M. A., Zmuidzinas, A., Manley, T. J., Levine, H., Smith, K. A., & Ritz, J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1509 · Cited by 435
Loetscher, P., Seitz, M., Baggiolini, M., & Moser, B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.569 · Cited by 417
The γc Family of Cytokines: Basic Biology to Therapeutic Ramifications
Leonard, W. J., Lin, J.-X., & O'Shea, J. J. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.028 · Cited by 383
Self-citationCaruso, A., Licenziati, S., Corulli, M., Canaris, A. D., De Francesco, M. A., Fiorentini, S., Peroni, L., Fallacara, F., Dima, F., Balsari, A., et al. (1997) · Cytometry · doi:10.1002/(sici)1097-0320(19970101)27:1<71::aid-cyto9>3.0.co;2-o · Cited by 376
Riddell, S. R., & Greenberg, P. D. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90210-m · Cited by 369
Kovanen, P. E., & Leonard, W. J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00203.x · Cited by 360
Self-citationRobertson, M. J., Soiffer, R. J., Wolf, S. F., Manley, T. J., Donahue, C., Young, D., Herrmann, S. H., & Ritz, J. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.3.779 · Cited by 354
Both integrated and differential regulation of components of the IL-2/IL-2 receptor system
Kim, H. P., Imbert, J., & Leonard, W. J. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.07.003 · Cited by 325
Self-citationMolecular Events Mediating T Cell Activation
Altman, A., Coggeshall, K. M., & Mustelin, T. (1990) · Advances in Immunology · doi:10.1016/s0065-2776(08)60756-7 · Cited by 291
The IL-2 cytokine family in cancer immunotherapy
Sim, G. C., & Radvanyi, L. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.018 · Cited by 278
Caligiuri, M. A., Murray, C., Robertson, M. J., Wang, E., Cochran, K., Cameron, C., Schow, P., Ross, M. E., Klumpp, T. R., & Soiffer, R. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116161 · Cited by 269
Nagel, J. E., Chopra, R. K., Chrest, F. J., McCoy, M. T., Schneider, E. L., Holbrook, N. J., & Adler, W. H. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113422 · Cited by 259
Metadata
- Authors
- Siegel, J. P., Sharon, M., Smith, P. L., & Leonard, W. J.
- Venue
- Science
- Published
- 1987-10-02
- Volume
- 238
- Issue
- 4823
- Pages
- 75-78
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2060148643
- Cited by
- 445
- References
- 19
- FWCI
- 22.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.